tickdelta
Sign in
Tables

Tables in the 10-Q of DEXCOM INC

48 tables with numbers, filed Jul 30, 2026. Each one downloads as an Excel file or a CSV (numbers are stored as numbers), with the filing's address in the last row. Only the layout is tidied (a "$" or ")" in a cell of its own is joined to its number); no value is changed. Open the filing on sec.gov ↗

← Filings of DXCM

Table 1 after “Contents”

Page
PART I. FINANCIAL INFORMATION
ITEM 1.Financial Statements
Condensed Consolidated Balance Sheets (unaudited) as of June 30, 2026 and December 31, 20254
Condensed Consolidated Statements of Operations (unaudited) for the three and six months ended June 30, 2026 and 20255
Condensed Consolidated Statements of Comprehensive Income (unaudited) for the three and six months ended June 30, 2026 and 20256
Condensed Consolidated Statements of Stockholders’ Equity (unaudited) for the three and six months ended June 30, 2026 and 20257
Condensed Consolidated Statements of Cash Flows (unaudited) for the six months ended June 30, 2026 and 20259

First 8 of 21 rows. The download has all of them.

Table 2 after “Contents”

(In millions, except share and par value data)June 30, 2026December 31, 2025
Assets
Current assets:
Cash and cash equivalents$1,105.0$917.7
Short-term marketable securities842.01,081.0
Accounts receivable, net1,257.71,216.1
Inventory726.4629.1
Prepaid and other current assets155.5189.4

First 8 of 37 rows. The download has all of them.

Table 3 after “Contents”

Three Months Ended June 30,Six Months Ended June 30,
(In millions, except per share data)2026202520262025
Revenue$1,308.4$1,157.1$2,500.3$2,193.1
Cost of sales478.4468.3920.0915.3
Gross profit830.0688.81,580.31,277.8
Operating expenses:
Research and development153.0148.2298.3293.4
Selling, general and administrative358.7328.0708.4638.1

First 8 of 18 rows. The download has all of them.

Table 4 after “Contents”

Three Months Ended June 30,Six Months Ended June 30,
(In millions)2026202520262025
Net income$249.1$179.8$448.6$285.2
Other comprehensive income (loss), net of tax:
Translation adjustments and other(15.7)81.9(22.2)91.9
Unrealized loss on marketable debt securities(0.5)(0.5)(2.8)(0.3)
Total other comprehensive income (loss), net of tax(16.2)81.4(25.0)91.6
Comprehensive income$232.9$261.2$423.6$376.8

Table 5 after “Contents”

Three Months Ended June 30, 2026
Accumulated Other Comprehensive Income (Loss)
(In millions)Common StockAdditional Paid-In CapitalTranslation Adjustments and OtherNet Unrealized Loss on Marketable SecuritiesRetained EarningsTreasury StockTotal Stockholders’ Equity
SharesAmount
Balance at March 31, 2026385.9$0.4$2,337.5$107.3$(1.1)$2,633.4$(2,120.6)$2,956.9
Issuance of common stock under equity incentive plans0.1———————
Common stock withheld related to net share settlement of equity awards——————(1.8)(1.8)
Purchases of treasury stock, including excise tax(8.6)—————(605.6)(605.6)

First 8 of 12 rows. The download has all of them.

Table 6 after “Contents”

Three Months Ended June 30, 2025
Accumulated Other Comprehensive Income (Loss)
(In millions)Common StockAdditional Paid-In CapitalTranslation Adjustments and OtherNet Unrealized Gain (Loss) on Marketable SecuritiesRetained EarningsTreasury StockTotal Stockholders’ Equity
SharesAmount
Balance at March 31, 2025392.1$0.4$2,142.2$1.6$0.6$1,703.0$(1,581.2)$2,266.6
Issuance of common stock under equity incentive plans0.1———————
Share-based compensation expense——45.3————45.3
Net income—————179.8—179.8

First 8 of 10 rows. The download has all of them.

Table 7 after “Contents”

Six Months Ended June 30, 2026
Accumulated Other Comprehensive Income (Loss)
(In millions)Common StockAdditional Paid-In CapitalTranslation Adjustments and OtherNet Unrealized Gain (Loss) on Marketable SecuritiesRetained EarningsTreasury StockTotal Stockholders’ Equity
SharesAmount
Balance at December 31, 2025384.8$0.4$2,281.5$113.8$1.2$2,433.9$(2,084.8)$2,746.0
Issuance of common stock under equity incentive plans1.5———————
Issuance of common stock for Employee Stock Purchase Plan0.2—12.7————12.7
Common stock withheld related to net share settlement of equity awards(0.5)—————(37.6)(37.6)

First 8 of 13 rows. The download has all of them.

Table 8 after “Contents”

Six Months Ended June 30, 2025
Accumulated Other Comprehensive Income (Loss)
(In millions)Common StockAdditional Paid-In CapitalTranslation Adjustments and OtherNet Unrealized Gain (Loss) on Marketable SecuritiesRetained EarningsTreasury StockTotal Stockholders’ Equity
SharesAmount
Balance at December 31, 2024390.7$0.4$2,093.8$(8.4)$0.4$1,597.6$(1,581.2)$2,102.6
Issuance of common stock under equity incentive plans1.3———————
Issuance of common stock for Employee Stock Purchase Plan0.2—14.2————14.2
Share-based compensation expense——79.5————79.5

First 8 of 11 rows. The download has all of them.

Table 9 after “Contents”

Six Months Ended June 30,
(In millions)20262025
Operating activities
Net income$448.6$285.2
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation and amortization135.3123.0
Share-based compensation82.379.5
Non-cash interest expense2.03.7

First 8 of 46 rows. The download has all of them.

Table 10 after “The following table sets forth the computation of basic and diluted net income per share:”

Three Months Ended June 30,Six Months Ended June 30,
(In millions, except per share data)2026202520262025
Net income$249.1$179.8$448.6$285.2
Add back interest expense, net of tax attributable to assumed conversion of senior convertible notes1.72.93.35.8
Net income - diluted$250.8$182.7$451.9$291.0
Net income per common share
Basic$0.65$0.46$1.17$0.73
Diluted$0.64$0.45$1.15$0.71

First 8 of 13 rows. The download has all of them.

Table 11 after “Outstanding anti-dilutive securities not included in the calculations of diluted net income per share attributable to common stockholders we”

Three Months Ended June 30,Six Months Ended June 30,
(In millions)2026202520262025
RSUs and PSUs1.41.21.01.2

Table 12 after “The following table summarizes financial assets that we measured at fair value on a recurring basis as of June 30, 2026, classified in accor”

Fair Value Measurements Using
(In millions)Level 1Level 2Level 3Total
Cash equivalents$409.0$—$—$409.0
Debt securities, available-for-sale:
U.S. government agencies (1)—325.0—325.0
Commercial paper—126.7—126.7
Corporate debt—390.3—390.3
Total debt securities, available-for-sale—842.0—842.0

First 8 of 12 rows. The download has all of them.

Table 13 after “The following table summarizes financial assets that we measured at fair value on a recurring basis as of December 31, 2025, classified in a”

Fair Value Measurements Using
(In millions)Level 1Level 2Level 3Total
Cash equivalents$392.8$—$—$392.8
Debt securities, available-for-sale:
U.S. government agencies (1)—357.3—357.3
Commercial paper—123.4—123.4
Corporate debt—600.3—600.3
Total debt securities, available-for-sale—1,081.0—1,081.0

First 8 of 12 rows. The download has all of them.

Table 14 after “Short-term debt marketable securities, consisting of available-for-sale debt securities were as follows:”

June 30, 2026
(In millions)Amortized CostGross Unrealized GainsGross Unrealized LossesEstimated Market Value
Debt securities, available-for-sale:
U.S. government agencies (1)$325.7$—$(0.7)$325.0
Commercial paper126.9—(0.2)126.7
Corporate debt391.4—(1.1)390.3
Total debt securities, available-for-sale$844.0$—$(2.0)$842.0

Table 15 after “Includes debt obligations issued by U.S. government-sponsored enterprises or U.S. government agencies.”

December 31, 2025
(In millions)Amortized CostGross Unrealized GainsGross Unrealized LossesEstimated Market Value
Debt securities, available-for-sale:
U.S. government agencies (1)$356.6$0.7$—$357.3
Commercial paper123.4——123.4
Corporate debt599.40.9—600.3
Total debt securities, available-for-sale$1,079.4$1.6$—$1,081.0

Table 16 after “We periodically review our portfolio of debt securities to determine if any investment is impaired due to credit loss or other potential val”

(In millions)June 30, 2026December 31, 2025
Raw materials$232.7$257.6
Work-in-process107.0105.0
Finished goods386.7266.5
Total inventory$726.4$629.1

Table 17 after “Contents”

(In millions)June 30, 2026December 31, 2025
Prepaid expenses$70.7$66.4
Deferred compensation plan assets22.120.0
Income tax receivables12.560.8
Indirect tax receivables13.013.0
Other current assets37.229.2
Total prepaid and other current assets$155.5$189.4

Table 18 after “Contents”

(In millions)June 30, 2026December 31, 2025
Building$389.1$319.7
Computer software and hardware98.987.8
Furniture and fixtures43.541.0
Land and land improvements57.858.3
Leasehold improvements303.8302.1
Machinery and equipment1,029.11,016.3
Construction in progress614.4593.5

First 8 of 11 rows. The download has all of them.

Table 19 after “million from December 31, 2025, reflecting the impact of the acquisition, partially offset by amortization expense recognized during the six”

(In millions)June 30, 2026December 31, 2025
Non-marketable equity securities$209.5$218.0
Capitalized software15.419.1
Long-term deposits24.017.2
Other assets24.824.4
Total other assets$273.7$278.7

Table 20 after “Contents”

(In millions)June 30, 2026December 31, 2025
Accounts payable trade$423.8$344.3
Accrued rebates1,652.01,487.6
Accrued tax, audit, and legal fees33.527.0
Accrued warranty5.610.4
Deferred compensation plan liabilities22.120.0
Income tax payable11.18.9
Other accrued liabilities43.445.8

First 8 of 9 rows. The download has all of them.

Table 21 after “Contents”

(In millions)June 30, 2026December 31, 2025
Accrued wages, bonus and taxes$101.6$134.6
Other accrued employee benefits34.734.6
Total accrued payroll and related expenses$136.3$169.2

Table 22 after “Contents”

(In millions)June 30, 2026December 31, 2025
Asset retirement obligation$20.0$20.6
Finance lease obligations52.353.8
Income tax payable51.146.6
Other liabilities27.416.1
Total other long-term liabilities$150.8$137.1

Table 23 after “Contents”

Three Months Ended June 30,Six Months Ended June 30,
(In millions)2026202520262025
Interest and dividend income$16.9$28.0$36.4$56.5
Interest expense(3.0)(4.7)(6.1)(9.4)
Net losses on equity investments(10.0)(0.4)(10.0)(4.6)
Other income (expense), net(4.7)5.6(6.9)6.6
Total other income (expense), net$(0.8)$28.5$13.4$49.1

Table 24 after “The carrying amounts of our senior convertible notes were as follows:”

(In millions)June 30, 2026December 31, 2025
Principal amount:
2028 Notes$1,250.0$1,250.0
Unamortized debt issuance costs(7.2)(9.1)
Carrying amount of senior convertible notes$1,242.8$1,240.9

Table 25 after “The following table summarizes the components of interest expense and the effective interest rates for our senior convertible notes:”

Three Months Ended June 30,Six Months Ended June 30,
(In millions)2026202520262025
Cash interest expense:
Contractual coupon interest (1)$1.2$2.0$2.4$3.9
Non-cash interest expense:
Amortization of debt issuance costs1.01.81.93.6
Total interest expense recognized on senior notes$2.2$3.8$4.3$7.5
Effective interest rate:

First 8 of 12 rows. The download has all of them.

Table 26 after “The fair value, based on trading prices (Level 1 inputs), of our senior convertible notes were as follows:”

Fair Value Measurements Using Level 1
(In millions)June 30, 2026December 31, 2025
2028 Notes$1,168.1$1,152.1

Table 27 after “The following table summarizes key details of the 2028 Notes:”

Senior Convertible NotesOffering Completion DateMaturity DateStated Interest RateAggregate Principal Amount IssuedNet Proceeds(1)Initial Conversion Rate(2)(per $1,000 principal amount)Conversion Price(per share)Settlement Methods(3)
2028 NotesMay 2023May 15, 20280.375%$1.25 billion$1.23 billion6.1571 shares$162.41Cash and/or shares
(1) Net proceeds are calculated by deducting the initial purchasers’ discounts and estimated costs directly related to the offering from the aggregate principal amount of the applicable series of notes.
(2) Subject to adjustments as defined in the applicable indentures.
(3) The 2028 Notes may be settled upon conversion in cash, stock, or a combination thereof, solely at our discretion.

Table 28 after “The following table outlines the conversion options related to our 2028 Notes:”

Summary of Conversions Rights at the Option of the Holders for the 2028 Notes, or the Notes
Conversion Rights at the Option of the HoldersHolders of the Notes have the ability to convert all or a portion of their notes in multiples of $1,000 principal amount, at their option prior to 5:00 p.m., New York City time, on the business day immediately preceding February 15, 2028 for the 2028 Notes only under the following circumstances:
Circumstance 1(1)During any calendar quarter commencing after the applicable period (and only during such calendar quarter), if the last reported sale price of Dexcom’s common stock for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the applicable conversion price for the Notes on each applicable trading day
Circumstance 2During the five business day period after any five consecutive trading day period in which the trading price per $1,000 principal amount of the Notes for each trading day of that five consecutive trading day period was less than 98% of the product of the last reported sale price of Dexcom’s common stock and the applicable conversion rate of the Notes on each such trading day
Circumstance 3If we call any or all of the Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date (only with respect to the notes called or deemed called for redemption)
Circumstance 4Upon the occurrence of specified corporate events
Circumstance 5(2)Holders of the Notes may convert all or a portion of their notes regardless of the foregoing circumstances prior to the close of business on the second scheduled trading day immediately preceding the maturity date
(1) Circumstance 1 is available after the calendar quarter ended September 30, 2023 for the 2028 Notes.

First 8 of 9 rows. The download has all of them.

Table 29 after “The following table outlines the conversion options related to our 2028 Notes:”

Summary of Conversion Right at the Option of the Company for the 2028 Notes
Conversion Right at Our Option(1)Dexcom may redeem for cash all or part of the Notes, at its option, if the last reported sale price of our common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which Dexcom provides notice of redemption. The redemption price will be equal to 100% of the principal amount of the Notes to be redeemed plus accrued and unpaid interest to, but excluding, the redemption date
(1) Dexcom does not have the right to redeem the 2028 Notes prior to May 20, 2026. Dexcom has the right to redeem the 2028 Notes on or after May 20, 2026 and prior to February 15, 2028.

Table 30 after “The following table sets forth information related to availability and outstanding borrowings on our Amended Credit Agreement as of June 30,”

(In millions)
Available principal amount$200.0
Letters of credit sub-facility25.0
Outstanding borrowings—
Outstanding letters of credit8.7
Total available balance$191.3

Table 31 after “The minimum and maximum range of applicable rates per annum with respect to any ABR Loan, Term Benchmark Revolving Loan, or RFR Revolving Lo”

RangeABR SpreadTerm Benchmark/RFR SpreadUnused Commitment Fee Rate
Minimum0.375%1.375%0.175%
Maximum1.000%2.000%0.250%

Table 32 after “Our share-based compensation expense is associated with RSUs, PSUs, and our Employee Stock Purchase Plan, or ESPP. The following table summa”

Three Months Ended June 30,Six Months Ended June 30,
(In millions)2026202520262025
Cost of sales$3.1$4.0$5.9$7.2
Research and development9.713.521.326.3
Selling, general and administrative26.227.855.146.0
Total share-based compensation expense$39.0$45.3$82.3$79.5

Table 33 after “The following table sets forth our segment information for revenue, measures of segment profit or loss, and significant expenses:”

Three Months Ended June 30,Six Months Ended June 30,
(In millions)2026202520262025
Revenue$1,308.4$1,157.1$2,500.3$2,193.1
Less:
Cost of sales (1)478.4468.3920.0915.3
Payroll related expenses231.8222.0456.2442.2
Stock-based compensation expense35.941.376.472.3
Marketing expense90.878.8176.4149.2

First 8 of 21 rows. The download has all of them.

Table 34 after “The following table sets forth our segment information for revenue, measures of segment profit or loss, and significant expenses:”

Three Months Ended June 30,Six Months Ended June 30,
(In millions)2026202520262025
Other segment disclosures
Depreciation and amortization (1)$68.2$63.0$135.3$123.0
Expenditures for long-lived assets$84.7$94.1$161.3$181.1
Significant noncash items other than depreciation and amortization expense:
Deferred income tax expense (benefit)$(0.3)$(8.9)$—$(14.7)
Net losses on equity investments$10.0$0.4$10.0$4.6

First 8 of 9 rows. The download has all of them.

Table 35 after “The following table presents our revenue disaggregated by major sales channel and geographic region:”

Three Months Ended June 30,
20262025
(In millions)United StatesInternationalTotalUnited StatesInternationalTotal
Distributor$893.5$208.9$1,102.4$800.0$177.8$977.8
Direct39.9166.1206.041.0138.3179.3
Total revenue$933.4$375.0$1,308.4$841.0$316.1$1,157.1

Table 36 after “The following table presents our revenue disaggregated by major sales channel and geographic region:”

Six Months Ended June 30,
20262025
(In millions)United StatesInternationalTotalUnited StatesInternationalTotal
Distributor$1,690.4$422.3$2,112.7$1,520.6$337.2$1,857.8
Direct75.3312.3387.670.9264.4335.3
Total revenue$1,765.7$734.6$2,500.3$1,591.5$601.6$2,193.1

Table 37 after “Contents”

Overview of Financial Results
The most important financial indicators that we use to assess our business are revenue, gross profit, operating income, net income, and operating cash flow.
Key Highlights for the Three Months Ended June 30, 2026 include the following:
RevenueGross ProfitOperating IncomeNet IncomeOperating Cash Flow
$1.31 billion$830.0 million$318.3 million$249.1 million$269.2 million
up 13% from the same period in 2025up 20% from the same period in 2025up 50% from the same period in 2025up 39% from the same period in 2025down 11% from the same period in 2025

Table 38 after “We ended the second quarter of 2026 with cash, cash equivalents and short-term marketable securities totaling $1.95 billion.”

Three Months Ended June 30, 2026 Compared to Three Months Ended June 30, 2025
Three Months Ended June 30,2026 - 2025
(In millions, except per share amounts)2026% of Revenue (1)2025% of Revenue (1)$ Change% Change
Revenue$1,308.4100%$1,157.1100%$151.313%
Cost of sales478.437%468.340%10.12%
Gross profit830.063.4%688.859.5%141.220%
Operating expenses:
Research and development153.012%148.213%4.83%

First 8 of 19 rows. The download has all of them.

Table 39 after “Contents”

Three Months Ended June 30,
20262025
(In millions)United StatesInternationalTotalUnited StatesInternationalTotal
Distributor$893.5$208.9$1,102.4$800.0$177.8$977.8
Direct39.9166.1206.041.0138.3179.3
Total revenue$933.4$375.0$1,308.4$841.0$316.1$1,157.1

Table 40 after “Contents”

Three Months Ended June 30, 2026 Compared to Three Months Ended June 30, 2025
Research and development expenseResearch and development expense was relatively flat due to the timing of project spend. We continue to believe that focused investments in research and development are critical to our future growth and competitive position in the marketplace, and to the development of new and enhanced products and services that are central to our core business strategy.
Selling, general and administrative expenseSelling, general and administrative expense increased primarily due to $12.1 million in incremental investments in advertising and marketing costs, $6.7 million in higher compensation and related costs, and $6.3 million in higher facilities-related costs.
Other income (expense), netOther income (expense), net, decreased primarily due to $11.1 million in lower interest and dividend income, $10.3 million in net foreign currency losses, and $9.6 million in net losses on equity investments. The decrease in interest income was driven by a decrease in the average invested balances and changes in market interest rates.
Income tax expenseThe income tax expense recorded for the three months ended June 30, 2026 and June 30, 2025 was primarily attributable to income tax expense from normal, recurring operations. The decrease in our effective tax rate for the three months ended June 30, 2026 compared to the same period in 2025 is primarily attributable to the commencement of our Malaysia tax holiday and higher pretax income in the current period.

Table 41 after “Contents”

Six Months Ended June 30, 2026 Compared to Six Months Ended June 30, 2025
Six Months Ended June 30,2026 - 2025
(In millions, except per share amounts)2026% of Revenue (1)2025% of Revenue (1)$ Change% Change
Revenue$2,500.3100%$2,193.1100%$307.214%
Cost of sales920.037%915.342%4.71%
Gross profit1,580.363.2%1,277.858.3%302.524%
Operating expenses:
Research and development298.312%293.413%4.92%

First 8 of 19 rows. The download has all of them.

Table 42 after “Contents”

Six Months Ended June 30,
20262025
(In millions)United StatesInternationalTotalUnited StatesInternationalTotal
Distributor$1,690.4$422.3$2,112.7$1,520.6$337.2$1,857.8
Direct75.3312.3387.670.9264.4335.3
Total revenue$1,765.7$734.6$2,500.3$1,591.5$601.6$2,193.1

Table 43 after “Contents”

Six Months Ended June 30, 2026 Compared to Six Months Ended June 30, 2025
Research and development expenseResearch and development expense was relatively flat due to the timing of project spend. We continue to believe that focused investments in research and development are critical to our future growth and competitive position in the marketplace, and to the development of new and updated products and services that are central to our core business strategy.
Selling, general and administrative expenseSelling, general and administrative expense increased primarily due to $27.2 million in incremental investments in advertising and marketing costs, $22.6 million in higher compensation and related costs, and $11.5 million in higher facilities-related costs.
Other income, netOther income, net, decreased primarily due to $20.1 million in lower interest and dividend income and $13.6 million in net foreign currency losses. The decrease in interest income was driven by a decrease in the average invested balances and changes in market interest rates.
Income tax expenseThe income tax expense recorded for the six months ended June 30, 2026 was primarily attributable to income tax expense from normal, recurring operations at an estimated annual effective tax rate of 21.8%, which includes the tax benefit related to the commencement of our Malaysia tax holiday, increased by discrete shortfalls recognized for share-based compensation for employees, net of nondeductible executive compensation. The income tax expense recorded for the six months ended June 30, 2025 was primarily attributable to income tax expense from normal, recurring operations at an estimated annual effective tax rate of 24.3%, increased by discrete shortfalls recognized for share-based compensation for employees, net of nondeductible executive compensation. The decrease in our effective tax rate for the six months ended June 30, 2026 compared to the same period in 2025 is primarily attributable to commencement of our Malaysia tax holiday and higher pretax income in the current period.

Table 44 after “The following table sets forth a summary of our cash flows and the primary changes in cash flows for the periods shown. See the condensed co”

Six Months Ended June 30,
(In millions)20262025$ Change
Net cash provided by operating activities$794.8$486.8$308.0
Net cash provided by investing activities31.336.6(5.3)
Net cash provided by (used in) financing activities(632.3)10.8(643.1)
Effect of exchange rate changes on cash, cash equivalents and restricted cash(7.7)18.8(26.5)
Increase in cash, cash equivalents and restricted cash$186.1$553.0$(366.9)

Table 45 after “The following table sets forth a summary of our cash flows and the primary changes in cash flows for the periods shown. See the condensed co”

Six Months Ended June 30, 2026 Compared to Six Months Ended June 30, 2025
Operating Cash Flows$163.4 million increase in net income
$94.0 million increase in net changes in operating assets and liabilities primarily due to the timing of sales and customer collections in accounts receivables
Investing Cash Flows$41.2 million increase in cash used for an acquisition in the second quarter of 2026
Financing Cash Flows$603.6 million increase in cash used to repurchase our common stock
$37.6 million increase in payments for taxes related to net share settlement of equity awards

Table 46 after “The following table provides information regarding repurchases of our shares of common stock during the three months ended June 30, 2026:”

PeriodTotal number of shares purchasedAverage price paid per share(1)Total number of shares purchased as part of publicly announced program(2)Maximum dollar value of shares that may yet be purchased under the program(in millions)(2)
4/01/2026 - 4/30/2026—$——$250.0
5/01/2026 - 5/31/20267,958,605$69.477,958,605$447.1
6/01/2026 - 6/30/2026627,941$75.03627,941$400.0
(1) Average price paid per share includes broker commissions.
(2) On May 1, 2025, we announced that our Board of Directors authorized and approved a share repurchase program of up to $750.0 million of our outstanding common stock, with a repurchase period ending no later than June 30, 2026. In May 2026, our Board of Directors terminated the existing 2025 Share Repurchase Program, of which $250.0 million remained available to be repurchased under the program. No shares were repurchased under the 2025 Share Repurchase Program during the three months ended June 30, 2026. On May 14, 2026, we announced that our Board of Directors authorized and approved a share repurchase program of up to $1.00 billion of our outstanding common stock, with a repurchase period ending no later than June 30, 2027.

Table 47 after “During the three months ended June 30, 2026, the following Section 16 officers and directors adopted, modified, or terminated a “Rule 10b5-1”

NameTitleActionAction DateAggregate Number of Shares to be SoldExpiration Date(1)
Nicholas AugustinosDirectorAdoption6/10/20268,0898/10/2027
Sadie SternExecutive Vice President, Chief People & Culture OfficerAdoption5/28/202630,7738/26/2027
Jereme SylvainExecutive Vice President, Chief Financial OfficerAdoption6/10/202611,5716/10/2027
(1) Each trading arrangement permitted or permits transactions through and including the date listed in the table.

Table 48 after “Contents”

Incorporated by Reference
Exhibit NumberExhibit DescriptionFormFile No.Date of First FilingExhibit NumberProvided Herewith
31.1Certification of Chief Executive Officer Pursuant to Securities Exchange Act Rule 13a-14(a).————X
31.2Certification of Chief Financial Officer Pursuant to Securities Exchange Act Rule 13a-14(a).————X
32.1**Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350 and Securities Exchange Act Rule 13a-14(b).————X
32.2**Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350 and Securities Exchange Act Rule 13a-14(b).————X
101.INSInline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL documentX
101.SCHInline XBRL Taxonomy Extension Schema DocumentX

First 8 of 13 rows. The download has all of them.